Back to today’s briefing

Story perspectives

Breakthrough Gene Therapy Shows Promise for Duchenne Dystrophy

2/20/2025

36 2

Summary

Story summary

Solid Biosciences' gene therapy, SGT-003, is making waves in the fight against Duchenne muscular dystrophy (DMD). In a recent clinical trial, three young boys showed remarkable progress, producing microdystrophin after just three months, signaling muscle stabilization and heart health improvements. With no serious side effects, the company is eager to expand the trial and pursue FDA accelerated approval.

1 of 1

Story summary

Solid Biosciences' gene therapy, SGT-003, is making waves in the fight against Duchenne muscular dystrophy (DMD). In a recent clinical trial, three young boys showed remarkable progress, producing microdystrophin after just three months, signaling muscle stabilization and heart health improvements. With no serious side effects, the company is eager to expand the trial and pursue FDA accelerated approval.